retatrutide clinical trial doses trials dosing Retatrutide vs Mounjaro (Tirzepatide): Which is Better? Retatrutide Dosage: a Guide -

These factors have led to the ADA/EASD recommendation that GLP-1 RAs be the preferred first injectable glucose-lowering agent for T2D (ahead of insulin therapy

For those looking for a more effective and uncomplicated approach to weight loss and improved metabolic health, bariatric surgery provides a safer and more reliable alternative

Side Effect Comparison Since both medications work through the same GLP-1 pathway, their side effect profiles are similar

The principal study group experienced significant decreases in both liver fat and waist circumference, roughly 20% less on average

It may not be suitable for individuals with liver or kidney disease, as these conditions can affect berberine metabolism and clearance

Health Canada approval would follow, potentially adding several months to a year